MOLNMolecular Partners AG American Depositary Shares

4.400USDMkt Cap: 165.05M $P/E:

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP03…

Key Statistics

Company
Market Cap165.05M $
Enterprise Value83.25M $
Revenue (TTM)
Gross Profit-36.66M $
Net Income (TTM)-61.65M $
Revenue/Share
Last Price4.400 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees134
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-16.41
PEG
EV/EBITDA-1.60
EV/Revenue
P/S
P/B1.88
EPS (TTM)-1.91
EPS (Forward)-0.26
52W Range
4.380100% of range4.400
52W High4.400 USD
52W Low4.380 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-76.74%
ROA-60.38%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-51.26M $
CapEx (TTM)714.00K $
FCF Margin
FCF Yield-15.27%
Net Debt-75.42M $
Net Debt/EBITDA1.45
Balance Sheet
Debt/Equity0.05
Current Ratio9.43
Quick Ratio9.21
Book Value/Sh2.253 USD
Cash/Share2.100 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)11.24 USD
Upside (mean)+155.4%
Target Range3.788 USD17.14 USD
$3.788+155.4% to mean$17.14
# Analysts5
Ownership
Shares Out.37.51M
Float19.92M
Insiders0.00%
Institutions9.58%
Short Interest
Short Ratio0.3d
Short % Float0.01%
Short % Out.0.00%
Shares Short1.39K
Short (prev mo.)1.75K
Technical
SMA 503.997 (+10.1%)
SMA 2004.228 (+4.1%)
Beta0.68
S&P 52W Chg21.00%
Avg Vol (30d)483
Avg Vol (10d)560
Technical Indicators
RSI (14)64.9
MACD0.0871
MACD Signal0.0633
MACD Hist.+0.0238
BB Upper4.419 USD
BB Middle4.124 USD
BB Lower3.828 USD
BB Width14.34%
ATR (14)0.0894 USD
Vol Ratio (20d)0.53x